Salmon pancreas disease: connect diagnosis and performance

Start with the production history

Pancreas disease in Atlantic salmon, Salmo salar, involves salmonid alphavirus, commonly abbreviated SAV, and tissue damage that can affect feeding, growth and survival. SAV is an RNA virus. Finding its genetic material in a fish establishes a different piece of evidence from showing that the infection accounts for the current production problem.

Deperasińska and colleagues reviewed SAV biology and associated disease in 2018. The diagnostic manual chapter consulted here was issued by the OIE in 2019. These sources support a durable clinical approach. Their descriptions of geographical distribution, commercial vaccines and regulation should not be treated as a current market or legal assessment.

For a farm team, the useful starting point is a dated account of changing appetite, swimming behaviour and body condition. Identify which production units changed first and what happened around the same time, including fish movements, handling and water conditions. Other infections and husbandry problems remain possible explanations. Reduced feeding or thin fish alone cannot identify SAV as the cause.

Examine the pattern across organs

Pancreas disease can damage the exocrine pancreas, heart muscle and skeletal muscle. Loss of pancreatic tissue can impair digestive function, while muscle injury may contribute to weakness and altered swimming. The extent of these changes differs among animals and across stages of an outbreak.

Histopathology shows where tissue injury occurs and how it is organised. The manual describes pancreatic, cardiac and skeletal muscle lesions developing at different times. A single organ collected at a single stage may therefore give an incomplete picture. The clinical timeline and the condition of the sampled fish should reach the pathologist alongside the specimens.

Other diseases can also involve the heart, muscle or pancreas. Gross examination does not reliably reveal every microscopic lesion, and poor body condition is not specific to pancreas disease. A defensible diagnosis combines the distribution of lesions with evidence of the agent and the observations made on the farm. It should also explain which alternatives remain plausible.

Agree the sampling routes before the visit

Molecular detection of SAV uses reverse transcription to convert viral RNA before PCR amplification. The OIE chapter identifies heart and mid-kidney as suitable tissues for agent detection. Its histological examination covers a broader tissue set, including pancreatic tissue associated with the pyloric caeca, heart and both red and white skeletal muscle, together with other organs.

These purposes require different specimen handling. Tissue for histology and tissue for RNA testing should enter separate preservation routes agreed with the laboratory. Sending everything in a histological fixative and later requesting molecular testing can undermine the investigation. Containers, preservation, transport and sample identification belong in the plan before fish are examined.

An investigation of clinically affected fish also differs from surveillance in a population without signs. The veterinarian should define the target units, the fish categories and the sampling effort around the decision that the result will support. Whether apparently unaffected animals add useful information depends on that question. Farm size alone cannot provide a universal sample number.

Interpret a positive result in time

A positive PCR result may occur during clinical disease, in a less visibly affected infection or after the acute episode. The manual reports positive RT-PCR findings persisting for months in some tissues following outbreaks. Detecting a target, finding compatible injury and measuring current production effects are related observations, but they should be recorded separately.

A negative result has limits too. Its meaning depends on the fish selected, the tissue sampled, the stage of infection and specimen quality. If clinical problems continue, the laboratory report should make clear what was examined and what the testing cannot exclude. Further examination or a revised sampling plan may be more appropriate than declaring the entire population free of disease.

The review describes several SAV subtypes and distinguishes pancreas disease in salmon from sleeping disease in rainbow trout. Shared viral ancestry does not make these presentations interchangeable. Species, rearing environment and laboratory findings remain essential when discussing typing or a possible source of infection. Historical subtype distributions should not be used to infer the origin of a new farm result.

Review the routes connecting production units

Horizontal transmission, including transmission through water, is documented. A biosecurity review should follow actual contacts among fish groups, equipment and working areas. Record stock origins, generations on site, shared equipment, fish movements, interventions and the handling of dead fish. A procedure that looks sound on paper may miss the route used during a busy production day.

Marine net pens cannot provide complete water separation. This limits what a physical barrier can achieve and makes movement records and coordinated health management valuable. During an episode, additional handling needs a clear purpose. Decisions about feeding and other interventions require veterinary assessment of the animals and local conditions, rather than a uniform response copied from another farm.

Vaccination, where relevant, requires a strategy checked against the current setting. Older references do not establish which product is available, authorised or appropriate today. They also cannot justify a treatment prescription. Confirming the disease, reviewing the applicable framework and managing the affected group come before choosing an intervention.

Keep measuring after appetite returns

Follow feeding, growth, size variation and mortality using clearly defined periods and production units. An apparent return to feeding does not prove that every fish has recovered digestive or muscle function. Comparable records help identify groups that remain behind and prevent a change in recording practice from being mistaken for recovery.

A usable group history brings together dated observations, suitable specimens, an integrated interpretation and documented decisions. It allows the team to separate detection of infection from its consequences and assess whether the measures taken address the problem seen. It also provides a basis for revising surveillance before the next production cycle.

Work through the investigation with Vetofish

Vetofish can help define the diagnostic question, organise specimen collection and interpret laboratory findings alongside production records. Our fish health expertise supports aquaculture operations in developing this approach, without suggesting that one laboratory result can explain every loss of performance.